MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 373 filers reported holding MEDIVATION INC in Q2 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $60,357,000 | +6.3% | 1,000,951 | -18.9% | 0.13% | +18.7% |
| Q1 2016 | $56,763,000 | -13.1% | 1,234,512 | -8.7% | 0.11% | +0.9% |
| Q4 2015 | $65,334,000 | -8.6% | 1,351,549 | -19.6% | 0.11% | -9.4% |
| Q3 2015 | $71,464,000 | -39.3% | 1,681,504 | +63.1% | 0.12% | -30.4% |
| Q2 2015 | $117,718,000 | -13.4% | 1,030,811 | -2.1% | 0.17% | -11.1% |
| Q1 2015 | $135,955,000 | +17.9% | 1,053,349 | -9.0% | 0.19% | +18.1% |
| Q4 2014 | $115,310,000 | -14.3% | 1,157,616 | -14.9% | 0.16% | -14.0% |
| Q3 2014 | $134,557,000 | +37.2% | 1,360,949 | +7.0% | 0.19% | +29.2% |
| Q2 2014 | $98,080,000 | +20.2% | 1,272,436 | +0.4% | 0.14% | +16.1% |
| Q1 2014 | $81,573,000 | +6.7% | 1,267,248 | +5.8% | 0.12% | +0.8% |
| Q4 2013 | $76,444,000 | +23.4% | 1,197,813 | +15.9% | 0.12% | +4.2% |
| Q3 2013 | $61,946,000 | – | 1,033,466 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |